Furthermore, IGFBP5 may affect the methylation of insulin-like growth factor 1/2, FAM20C, and other molecules, thereby regulating the activation of the PI3K-Akt signaling pathway and facilitating CRC progression.37 Here, FAM20C is linked to colorectal carcinoma.